Navigation Links
Vessix to Present V2 Renal Denervation System™ for Hypertension at LINC 2012
Date:1/19/2012

LAGUNA HILLS, Calif., Jan. 18, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that the first public presentation of its new percutaneous V2 Renal Denervation System™ for the treatment of medication-resistant hypertension will be made at LINC 2012 in Leipzig, Germany on Thursday, January 26, 2012. 

Renal denervation is a new percutaneous catheter-based technique for the treatment of medication resistant or uncontrolled hypertension. The new V2 Renal Denervation System is designed to be faster, easier to deploy and less invasive for the patient than the alternatives available today in the market.

The presentation, titled "Radiofrequency balloon-mediated renal denervation: The V2 Catheter by Vessix Vascular," will be made by Prof. med. Horst Sievert during a session for new emerging technologies for renal denervation chaired by Krishna Rocha-Singh, M.D.

Dr. Sievert, a globally recognized interventional cardiologist based in Frankfurt, Germany, is a key opinion leader in the field of renal denervation. 

Vessix's new device, the V2 System for the treatment of medication-resistant hypertension, is an over-the-wire, balloon catheter with electrodes and thermistors mounted on the exterior of the balloon to facilitate the delivery of RF energy to the nerves surrounding the renal artery. Vessix will begin its first-in-man clinical study next month.

Key benefits of the Vessix approach to renal denervation include:

  • Therapy is delivered via a balloon catheter that is quite familiar to interventional cardiologists and other physicians, thereby increasing the usability and safety profile of the device.
  • Ability to deliver RF treatment in as little as thirty (30) seconds per artery, which is significantly faster than the only other competitively marketed renal denervation
    '/>"/>

    • SOURCE Vessix Vascular, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2

    Related medicine technology :

    1. Vessix Vascular Completes $23 Million Financing
    2. Intellect Neurosciences, Inc. to Present at BIO Asia International Conference
    3. Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets Eighth Annual Equity Conference
    4. Bacterin to Present at the Noble 8th Annual Equity Conference on January 17, 2012
    5. MiMedx Group, Inc. to Present at the Noble Capital Markets 8th Annual Equity Conference
    6. Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI): Phase III Data on Bayers Investigational Compound Regorafenib (BAY 73-4506) in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Or
    7. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
    8. Ultra Clean to Present at the 14th Annual Needham Growth Conference
    9. nContacts Cardiac Ablation Technology to be Presented in Two Noteworthy Posters at Boston Atrial Fibrillation Symposium 2012
    10. WuXi PharmaTech Provides Update of 2011 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
    11. Ambit Biosciences to Present at 30th Annual J.P. Morgan Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/16/2013)... May 17, 2013 Singapore,s ... Switzerland,s Cytos Biotechnology AG today announced ... Phase 1 clinical trial with their H1N1 influenza vaccine candidate ... In this first Phase 1 clinical trial, the safety and ... protect against H1N1 influenza infection will be evaluated. ...
    (Date:5/16/2013)... 2013  PTC Therapeutics, Inc., today announced that it ... the U.S. Securities and Exchange Commission ("SEC") relating to ... The number of shares to be offered and the ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... book-running managers for the offering. Cowen and Company is ...
    (Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
    Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
    ... Safety and Efficacy of Tengion,s Neo-Bladder Construct ... in Spinal Cord Injury Patients, ... medicine, announced today it has initiated a Phase 2,multi-center clinical trial ... study is being conducted in 10 adult,patients with neurogenic bladder due ...
    ... risk in ... with osteoporosis, INDIANAPOLIS, Sept. 14 Today, Eli Lilly ... and Drug Administration,(FDA) has approved its osteoporosis drug EVISTA(R) (raloxifene ... breast cancer in two populations:,postmenopausal women with osteoporosis and postmenopausal ...
    Cached Medicine Technology:Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 2Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 3FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 2FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 3FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 4FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 5FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women 6
    (Date:5/18/2013)... 18, 2013) A ground-breaking advance in colonoscopy ... to research presented today at Digestive Disease Week ... withdrawal time for colonoscopies and exploring safer methods ... doctors use a device called a colonoscope to ... cancer allows a doctor to look for precancerous ...
    (Date:5/18/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) -- ... drink, but new research shows that college women are more ... basis than are college men. Much of this ... safe on a weekly basis is much lower for women ... 14 for men. But, there,s good reason for that difference. ...
    (Date:5/18/2013)... Family Magazine of Washington DC was awarded ... Media Consulting, Inc. in the category of Summer Camps ... dedication of the areas best in the ultimate guide on ... better than Brenda Hyde, a mother of four and publisher ... about the vast resources available to them in the DC ...
    (Date:5/18/2013)... Simple changes in a person’s every ... drinking more water can lead to substantial health benefits, ... lifestyle overall. Diet Doc understands that overcoming ... can be difficult and often requires the use of ... help patients get over initial weight loss hurdles. In ...
    (Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
    Breaking Medicine News(10 mins):Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
    ... is a disease whose cause and cure are not studied ... date//. It is a lung disease characterized by scarring in ... organ (lung). Statistics show that approximately 83,000 Americans ... every year. Ten years ago Jean Thompson became a ...
    ... star Bono would be the Editor for 'The Independent' newspaper ... the deadly face of AIDS in the African continent. ... his editorial talent would also encourage various corporate giants to ... such as American Express, Giorgio Armani, Converse and Gap have ...
    ... who are in the habit of going for tattoos, ... facing problems during childbirth, reported the German medical// journal ... prevent doctors from applying local anesthesia during delivery. ... precisely where doctors inject the painkiller along the spine. ...
    ... Madhya Pradesh due to pregnancy related complications, owing to poverty, lack ... the National Family Health Survey (NFHS), the Maternal Mortality rate (MMR) ... of every 100,000 women, 498 die either while delivering a baby ... ,Taking the Census figures, about 1.9 million children are born in ...
    ... experts have said that India is planning to start ... are infected with HIV// and need anti-HIV therapy to ... AIDS Control Organisation and Indian paediatricians are starting to ... drugs for children and provide training to medical professionals ...
    ... star died in a freak accident, after he was dragged to ... after stealing Koster’s car. , ,Koster had beseeched the ... rob his car, as per police reports. Apparently the car was ... , ,Witnesses informed the police that they saw Dowds driving ...
    Cached Medicine News:Health News:Lesser Know Facts about Idiopathic Pulmonary Fibrosis (IPF) 2Health News:At Least 25 Women Die Of Maternity Complications In MP Everyday 2Health News:India To Estimate The Number Of Children Infected With HIV/AIDS 2
    Spurling-Kerrison (Colclough) Laminectomie Rongeur. 15 cm - 6, thick footplate, large handle, 40 up-cutting, jaws 3 mm wide....
    Kerrison (Micro) Laminectomie Rongeur, with ejector. 18 cm - 7 1/8, with thick footplate, small handle, 90 up-cutting, jaws 2 mm wide....
    ... Instrument Set offers maximum distraction with minimal ... by the Tangent Posterior Impacted Instrument Set ... to reproduce the technique. Set offers 9 ... body distraction. A variety of sizes of ...
    Regulates physiological flow within normal ranges of Intraventricular Pressure (IVP) in the supine, sitting or standing position....
    Medicine Products: